{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:37:57Z","timestamp":1793410677009,"version":"4.5.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"St. Louis University Research Institute","award":["UG1 DA050207"],"award-info":[{"award-number":["UG1 DA050207"]}]},{"name":"Washington University Institute of Clinical"},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR002345"],"award-info":[{"award-number":["UL1 TR002345"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Study Objectives<\/jats:title>\n                  <jats:p>In adult populations, women are more likely than men to be prescribed benzodiazepines. However, such disparities have not been investigated in people with opioid use disorder (OUD) and insomnia receiving buprenorphine, a population with particularly high sedative\/hypnotic receipt. This retrospective cohort study used administrative claims data from Merative MarketScan Commercial and MultiState Medicaid Databases (2006\u20132016) to investigate sex differences in the receipt of insomnia medication prescriptions among patients in OUD treatment with buprenorphine.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We included people aged 12\u201364 years with diagnoses of insomnia and OUD-initiating buprenorphine during the study timeframe. The predictor variable was sex (female versus male). The primary outcome was receipt of insomnia medication prescription within 60 days of buprenorphine start, encompassing benzodiazepines, Z-drugs, or non-sedative\/hypnotic insomnia medications (e.g. hydroxyzine, trazodone, and mirtazapine). Associations between sex and benzodiazepine, Z-drug, and other insomnia medication prescription receipt were estimated using Poisson regression models.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Our sample included 9510 individuals (female n\u2005=\u20054637; male n\u2005=\u20054873) initiating buprenorphine for OUD who also had insomnia, of whom 6569 (69.1%) received benzodiazepines, 3891 (40.9%) Z-drugs, and 8441 (88.8%) non-sedative\/hypnotic medications. Poisson regression models, adjusting for sex differences in psychiatric comorbidities, found female sex to be associated with a slightly increased likelihood of prescription receipt: benzodiazepines (risk ratio [RR], RR\u2005=\u20051.17 [1.11\u20131.23]), Z-drugs (RR\u2005=\u20051.26 [1.18\u20131.34]), and non-sedative\/hypnotic insomnia medication (RR\u2005=\u20051.07, [1.02\u20131.12]).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Sleep medications are commonly being prescribed to individuals with insomnia in OUD treatment with buprenorphine, with sex-based disparities indicating a higher prescribing impact among female than male OUD treatment patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/sleep\/zsad083","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T10:19:17Z","timestamp":1679912357000},"source":"Crossref","is-referenced-by-count":10,"title":["Benzodiazepine, Z-drug, and sleep medication prescriptions in male and female people with opioid use disorder on buprenorphine and comorbid insomnia: an analysis of multistate insurance claims"],"prefix":"10.1093","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5560-458X","authenticated-orcid":false,"given":"Caitlin E","family":"Martin","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology and VCU Institute for Drug and Alcohol Studies, Virginia Commonwealth University School of Medicine , Richmond, VA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hetal","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Washington University School of Medicine , St. Louis, MO , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9788-8813","authenticated-orcid":false,"given":"Joseph M","family":"Dzierzewski","sequence":"additional","affiliation":[{"name":"National Sleep Foundation , Washington DC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F Gerard","family":"Moeller","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Virginia Commonwealth University , Richmond, VA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J","family":"Bierut","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Washington University School of Medicine , St. Louis, MO , USA"},{"name":"Alvin J Siteman Cancer Center, Barnes Jewish Hospital , St. Louis, MO , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"Grucza","sequence":"additional","affiliation":[{"name":"Departments of Family and Community Medicine and Health and Outcomes Research, St. Louis University , St. Louis, MO , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6595-695X","authenticated-orcid":false,"given":"Kevin Y","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Washington University School of Medicine , St. Louis, MO , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,3,27]]},"reference":[{"issue":"7288","key":"2023101012222773100_CIT0001","first-page":"742","article-title":"Benzodiazepines","volume":"322","author":"Yamey","year":"2001","journal-title":"BMJ"},{"issue":"2","key":"2023101012222773100_CIT0002","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/1468-0424.00300","article-title":"\u201cMother\u2019s Little Helper\u201d: the crisis of psychoanalysis and the Miltown resolution","volume":"15","author":"Metzl","year":"2003","journal-title":"Gend Hist."},{"issue":"6900","key":"2023101012222773100_CIT0003","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/bmj.307.6900.363","article-title":"Sex-differences among recipients of benzodiazepines in Dutch general-practice.","volume":"307","author":"Vanderwaals","year":"1993","journal-title":"BMJ"},{"issue":"5","key":"2023101012222773100_CIT0004","doi-asserted-by":"crossref","first-page":"E290","DOI":"10.1016\/S2666-7568(21)00054-4","article-title":"Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens.","volume":"2","author":"Rochon","year":"2021","journal-title":"Lancet Health Longev."},{"issue":"6","key":"2023101012222773100_CIT0005","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00127-020-01989-4","article-title":"The influence of prescriber and patient gender on the prescription of benzodiazepines: evidence for stereotypes and biases?","volume":"56","author":"McIntyre","year":"2021","journal-title":"Soc Psych Psych Epid."},{"issue":"6","key":"2023101012222773100_CIT0006","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/bcp.13570","article-title":"Benzodiazepine and Z-drug prescribing in Ireland: analysis of national prescribing trends from 2005 to 2015.","volume":"84","author":"Cadogan","year":"2018","journal-title":"Br J Clin Pharmacol."},{"issue":"9","key":"2023101012222773100_CIT0007","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11920-018-0940-9","article-title":"Sex differences in insomnia: from epidemiology and etiology to intervention","volume":"20","author":"Suh","year":"2018","journal-title":"Curr Psychiatry Rep."},{"issue":"1","key":"2023101012222773100_CIT0008","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/sleep\/29.1.85","article-title":"Sex differences in insomnia: a meta-analysis","volume":"29","author":"Zhang","year":"2006","journal-title":"Sleep."},{"issue":"2","key":"2023101012222773100_CIT0009","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/jamapsychiatry.2018.3537","article-title":"Anxiety, depression, and insomnia among adults with opioid dependence treated with extended-release naltrexone vs buprenorphine-naloxone: a randomized clinical trial and follow-up study (vol 76, pg 127, 2018).","volume":"76","author":"Latif","year":"2019","journal-title":"JAMA Psychiat."},{"key":"2023101012222773100_CIT0010","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.sleep.2021.05.021","article-title":"A review of sleep disturbance in adults prescribed medications for opioid use disorder: potential treatment targets for a highly prevalent, chronic problem","volume":"84","author":"Wilkerson","year":"2021","journal-title":"Sleep Med."},{"issue":"2-3","key":"2023101012222773100_CIT0011","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.drugalcdep.2007.03.008","article-title":"Benzodiazepine prescription for patients in opioid maintenance treatment in Norway","volume":"90","author":"Bramness","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"2023101012222773100_CIT0012","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.trsl.2021.03.006","article-title":"At the intersection of sleep deficiency and opioid use: mechanisms and therapeutic opportunities","volume":"234","author":"Greenwald","year":"2021","journal-title":"Transl Res."},{"key":"2023101012222773100_CIT0013","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1037\/pha0000477","article-title":"Sleep disturbance as a therapeutic target to improve opioid use disorder treatment","volume":"30","author":"Huhn","year":"2021","journal-title":"Exp Clin Psychopharmacol."},{"issue":"1","key":"2023101012222773100_CIT0014","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41386-019-0465-x","article-title":"Drugs, sleep, and the addicted brain","volume":"45","author":"Valentino","year":"2020","journal-title":"Neuropsychopharmacology."},{"issue":"7","key":"2023101012222773100_CIT0015","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1176\/appi.ajp.2020.20081174","article-title":"Association between benzodiazepine or Z-drug prescriptions and drug-related poisonings among patients receiving buprenorphine maintenance: a case-crossover analysis","volume":"178","author":"Xu","year":"2021","journal-title":"Am J Psychiatry."},{"issue":"5","key":"2023101012222773100_CIT0016","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/pds.3434","article-title":"Estimation using all available covariate information versus a fixed look-back window for dichotomous covariates.","volume":"22","author":"Brunelli","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"2023101012222773100_CIT0017","doi-asserted-by":"crossref","first-page":"108130","DOI":"10.1016\/j.drugalcdep.2020.108130","article-title":"Age disparities in six-month treatment retention for opioid use disorder","volume":"213","author":"Mintz","year":"2020","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"2023101012222773100_CIT0018","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.chest.2020.09.249","article-title":"Disparities in sleep health and potential intervention models: a focused review","volume":"159","author":"Billings","year":"2021","journal-title":"Chest."},{"issue":"7","key":"2023101012222773100_CIT0019","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol."},{"key":"2023101012222773100_CIT0020","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1471-2288-14-82","article-title":"Comparison of robustness to outliers between robust Poisson models and log-binomial models when estimating relative risks for common binary outcomes: a simulation study","volume":"14","author":"Chen","year":"2014","journal-title":"BMC Med Res Methodol."},{"issue":"4","key":"2023101012222773100_CIT0021","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1532-5415.2012.03923.x","article-title":"American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults","volume":"60","author":"American Geriatrics Society Beers Criteria Update Expert P","year":"2012","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"2023101012222773100_CIT0022","doi-asserted-by":"crossref","first-page":"e1002965","DOI":"10.1371\/journal.pmed.1002965","article-title":"Prescription of benzodiazepines, z-drugs, and gabapentinoids and mortality risk in people receiving opioid agonist treatment: observational study based on the UK Clinical Practice Research Datalink and Office for National Statistics death records","volume":"16","author":"Macleod","year":"2019","journal-title":"PLoS Med."},{"issue":"3","key":"2023101012222773100_CIT0023","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/15360288.2010.503265","article-title":"Utah clinical guidelines on prescribing opioids for treatment of pain","volume":"24","author":"Rolfs","year":"2010","journal-title":"J Pain Palliat Care Pharmacother."},{"key":"2023101012222773100_CIT0024","year":"2022"},{"issue":"2","key":"2023101012222773100_CIT0025","doi-asserted-by":"crossref","first-page":"343","DOI":"10.5665\/sleep.3410","article-title":"National use of prescription medications for insomnia: NHANES 1999-2010","volume":"37","author":"Bertisch","year":"2014","journal-title":"Sleep."},{"issue":"4","key":"2023101012222773100_CIT0026","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.mcna.2018.02.012","article-title":"Sleep management among patients with substance use disorders","volume":"102","author":"Chakravorty","year":"2018","journal-title":"Med Clin North Am."},{"issue":"1","key":"2023101012222773100_CIT0027","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/0269881116675508","article-title":"Benzodiazepine maintenance in opiate substitution treatment: good or bad? A retrospective primary care case-note review","volume":"31","author":"Bakker","year":"2017","journal-title":"J Psychopharmacol."},{"issue":"5","key":"2023101012222773100_CIT0028","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/add.14886","article-title":"Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine","volume":"115","author":"Park","year":"2020","journal-title":"Addiction."},{"issue":"10250","key":"2023101012222773100_CIT0029","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)31561-0","article-title":"Sex and gender: modifiers of health, disease, and medicine","volume":"396","author":"Mauvais-Jarvis","year":"2020","journal-title":"Lancet."},{"key":"2023101012222773100_CIT0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.sleh.2022.07.004","article-title":"Gender differences in the prevalence of and trends in sleep patterns and prescription medications for insomnia among US adults, 2005 to 2018","author":"Zuo","year":"2022","journal-title":"Sleep Health"},{"issue":"6","key":"2023101012222773100_CIT0031","first-page":"470","article-title":"Mother\u2019s little helper? Contrasting accounts of benzodiazepine and methadone use among drug-dependent parents in the UK","volume":"21","author":"Chandler","year":"2014","journal-title":"Drugs."},{"issue":"1","key":"2023101012222773100_CIT0032","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1186\/s12889-022-14161-1","article-title":"Associations between sleep deficit and academic achievement-triangulation across time and subject domains among students and teachers in TIMSS in Norway.","volume":"22","author":"Vik","year":"2022","journal-title":"BMC Public Health."},{"issue":"8","key":"2023101012222773100_CIT0033","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1037\/bul0000102","article-title":"Gender differences in depression in representative national samples: meta-analyses of diagnoses and symptoms","volume":"143","author":"Salk","year":"2017","journal-title":"Psychol Bull."},{"key":"2023101012222773100_CIT0034","doi-asserted-by":"crossref","first-page":"106608","DOI":"10.1016\/j.addbeh.2020.106608","article-title":"Sex differences in benzodiazepine misuse among adults with substance use disorders.","volume":"112","author":"McHugh","year":"2021","journal-title":"Addict Behav."},{"issue":"1","key":"2023101012222773100_CIT0035","doi-asserted-by":"crossref","first-page":"e187399","DOI":"10.1001\/jamanetworkopen.2018.7399","article-title":"Patterns in outpatient benzodiazepine prescribing in the United States","volume":"2","author":"Agarwal","year":"2019","journal-title":"JAMA Netw Open."},{"issue":"2","key":"2023101012222773100_CIT0036","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1124\/pharmrev.120.000206","article-title":"Sex- and gender-based pharmacological response to drugs","volume":"73","author":"Mauvais-Jarvis","year":"2021","journal-title":"Pharmacol Rev."},{"key":"2023101012222773100_CIT0037","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2147\/NSS.S169312","article-title":"Are sleep patterns influenced by race\/ethnicity - a marker of relative advantage or disadvantage? Evidence to date","volume":"11","author":"Johnson","year":"2019","journal-title":"Nat Sci Sleep"},{"issue":"5","key":"2023101012222773100_CIT0038","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1177\/00333549211041554","article-title":"Need for and receipt of substance use disorder treatment among adults, by gender, in the United States","volume":"137","author":"Martin","year":"2022","journal-title":"Public Health Rep."},{"issue":"1","key":"2023101012222773100_CIT0039","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/lgbt.2019.0066","article-title":"Substance use among a national sample of sexual and gender minority adolescents: intersections of sex assigned at birth and gender identity","volume":"7","author":"Watson","year":"2020","journal-title":"LGBT Health"},{"key":"2023101012222773100_CIT0040","author":"NIMHD"},{"key":"2023101012222773100_CIT0041","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev-publhealth-040119-094412","article-title":"Sleep health: an opportunity for public health to address health equity","volume":"41","author":"Hale","year":"2020","journal-title":"Annu Rev Public Health."},{"issue":"1","key":"2023101012222773100_CIT0042","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1186\/s12889-020-09856-2","article-title":"A comprehensive multivariate model of biopsychosocial factors associated with opioid misuse and use disorder in a 2017-2018 United States national survey","volume":"20","author":"Montiel Ishino","year":"2020","journal-title":"BMC Public Health."},{"key":"2023101012222773100_CIT0043","doi-asserted-by":"crossref","first-page":"109337","DOI":"10.1016\/j.drugalcdep.2022.109337","article-title":"Short communication: relationship between social determinants and opioid use disorder treatment outcomes by gender","volume":"232","author":"Parlier-Ahmad","year":"2022","journal-title":"Drug Alcohol Depend."},{"issue":"10","key":"2023101012222773100_CIT0044","doi-asserted-by":"crossref","first-page":"e2131012","DOI":"10.1001\/jamanetworkopen.2021.31012","article-title":"Trends in the use of benzodiazepines, Z-hypnotics, and serotonergic drugs among us women and men before and during the COVID-19 pandemic","volume":"4","author":"Milani","year":"2021","journal-title":"JAMA Netw Open."},{"issue":"6","key":"2023101012222773100_CIT0045","doi-asserted-by":"crossref","first-page":"e2215425","DOI":"10.1001\/jamanetworkopen.2022.15425","article-title":"Analysis of urine drug test results from substance use disorder treatment practices and overdose mortality rates, 2013-2020","volume":"5","author":"Whitley","year":"2022","journal-title":"JAMA Netw Open."}],"container-title":["SLEEP"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/sleep\/advance-article-pdf\/doi\/10.1093\/sleep\/zsad083\/50147551\/zsad083.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/sleep\/article-pdf\/46\/6\/zsad083\/51975996\/zsad083.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/sleep\/article-pdf\/46\/6\/zsad083\/51975996\/zsad083.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T12:26:06Z","timestamp":1696940766000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/sleep\/article\/doi\/10.1093\/sleep\/zsad083\/7086656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,27]]},"references-count":45,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,3,27]]},"published-print":{"date-parts":[[2023,6,13]]}},"URL":"https:\/\/doi.org\/10.1093\/sleep\/zsad083","relation":{},"ISSN":["0161-8105","1550-9109"],"issn-type":[{"value":"0161-8105","type":"print"},{"value":"1550-9109","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,6,1]]},"published":{"date-parts":[[2023,3,27]]},"article-number":"zsad083"}}